edoc
Home
Policies
About
Statistics
Contact
Login
Statistics Overview
All items
> Item: Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06)
University structure
Item type
UniBasel Contributors
EPrint ID
Select dates:
Start Date :
End Date :
-OR- select a range:
Past month
Past 6 months
Past year
All
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
General
Comparison per year
Summary
Advanced
Deposits
Requests
Downloads
Export as
JSON
CSV
XML
Activity Overview
0
Downloads
173
Hits
